viscum album/neoplasms

Linkul este salvat în clipboard

Alegeți tipul de sortare

13 rezultate

Trial of Mistletoe Extract in Patients With Advanced Solid Tumors

Numai utilizatorii înregistrați pot traduce articole

This study is a Phase I study that consists of two phases: a dose escalation phase and an expansion phase. The dose escalation phase will be used to evaluate the safety and toxicity of Helixor® M (mistletoe extract). An accelerated titration design (ATD) will be utilized to determine the MTD. The

Mistletoe Therapy in Primary and Recurrent Inoperable Pancreatic Cancer

Numai utilizatorii înregistrați pot traduce articole

Extracts from European mistletoe (Viscum album L.) have been used as complementary cancer therapy since the 1920s. To date over 160 clinical studies on mistletoe in cancer therapy have been conducted with varying quality; the therapy is still controversial. Best evidence is found for increase of

Therapeutic Instillation of Mistletoe

Numai utilizatorii înregistrați pot traduce articole

This is a randomized, open-label, active-controlled, prospective, multinational Phase III confirmative study with 2 treatment groups and an adaptive design (Bauer and Köhne, 1994). The study is designed to compare the efficacy of treatment with abnobaVISCUM® 900 with Mitomycin C (MMC). Patients with

RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients

Numai utilizatorii înregistrați pot traduce articole

Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)

Numai utilizatorii înregistrați pot traduce articole

see summary

Iscador Qu as Supportive Treatment in Colorectal Cancer (Union International Cancer Control, UICC Stages II-IV)

Numai utilizatorii înregistrați pot traduce articole

see summary

Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.

Numai utilizatorii înregistrați pot traduce articole

The study design is to include 90 subjects. All subjects are treated with the common chemotherapy treatment. 50 percent will be treated with Iscador as combination with their common chemotherapy regimen. Common chemotherapy regimen used for NSCLC: Carboplatin and Gemcitabine. All study participants

Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study

Numai utilizatorii înregistrați pot traduce articole

The study consists of three parts. Part 1 is a prospective non-randomized feasibility study in patients with breast cancer after primary surgery during chemotherapy or endocrine therapy comparing blood count, lymphocytes, quality of life and local and general side effects between the groups Part 2

Iscar for Supplemental Care in Stage IV Lung Cancer

Numai utilizatorii înregistrați pot traduce articole

See Brief Summary

Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy

Numai utilizatorii înregistrați pot traduce articole

OBJECTIVES: - Determine whether supplemental treatment with mistletoe increases immune function (as determined by total lymphocyte count, eosinophil count, and lymphocyte subset analysis) in patients with stage IIIB or IV non-small cell lung cancer receiving palliative chemotherapy. - Determine the

Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors

Numai utilizatorii înregistrați pot traduce articole

OBJECTIVES: - Determine the maximum tolerated dose of gemcitabine and mistletoe in patients with advanced solid tumors. - Determine the toxic effects of this regimen in these patients. - Determine the pharmacokinetic effects of gemcitabine with and without mistletoe in these patients. - Determine

Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors

Numai utilizatorii înregistrați pot traduce articole

OBJECTIVES: - Determine the maximum tolerated dose and dose-limiting toxicity of mistletoe lectin (recombinant viscumin) in patients with advanced solid tumors who have failed standard therapy. - Determine the optimal biologically active dose of mistletoe lectin based on analysis of specific

Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Numai utilizatorii înregistrați pot traduce articole

OBJECTIVES: - Determine the maximum tolerated dose and dose-limiting toxicity of mistletoe lectin (recombinant viscumin) in patients with advanced solid tumors who have failed standard therapy. - Determine the pharmacokinetics of this regimen in these patients. - Determine whether induction of

Alăturați-vă paginii
noastre de facebook

Herbal & Natural Medicine

Cea mai completă bază de date cu plante medicinale susținută de știință

Funcționează în 55 de limbi
Cure pe bază de plante susținute de știință
Recunoașterea ierburilor după imagine
Harta GPS interactivă - etichetați ierburile în locație (în curând)
Citiți publicațiile științifice legate de căutarea dvs.
Căutați plante medicinale după efectele lor
Organizați-vă interesele și rămâneți la curent cu noutățile de cercetare, studiile clinice și brevetele

Tastați un simptom sau o boală și citiți despre plante care ar putea ajuta, tastați o plantă și vedeți boli și simptome împotriva cărora este folosit.
* Toate informațiile se bazează pe cercetări științifice publicate